Tight interdependence between AD and T2DM discussed above in terms of Aβ and amylin interaction raises an additional question if diabetes may also affect the development or aggravation of tau pathology in AD and other tauopathies, and if tau and amylin may directly interact or not. The gene discussed is MAPT; the disease is type 2 diabetes mellitus.